Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Consolidated Net Income (2024 - 2025)

Historic Consolidated Net Income for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$14.2 million.

  • Beta Bionics' Consolidated Net Income fell 3998.62% to -$14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.4 million, marking a year-over-year decrease of 10292.93%. This contributed to the annual value of -$41.3 million for FY2024, which is 2133.36% down from last year.
  • Latest data reveals that Beta Bionics reported Consolidated Net Income of -$14.2 million as of Q3 2025, which was down 3998.62% from -$16.9 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Consolidated Net Income ranged from a high of -$8.3 million in Q1 2024 and a low of -$16.9 million during Q2 2025